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Background: IVF is a costly treatment option for women, their partners, and the public. Therefore new therapies
that improve reproductive and health outcomes are highly desirable. There is a growing body of research
evaluating the effect of acupuncture administered during IVF, and specifically on the day of embryo transfer (ET).
Many trials are heterogeneous and results inconsistent. There remains insufficient evidence to determine if
acupuncture can enhance live birth rates when used as an adjunct to IVF treatment.
The study will determine the clinical effectiveness of acupuncture with improving the proportion of women
undergoing IVF having live births. Other objectives include: determination of the cost effectiveness of IVF with
acupuncture; and examination of the personal and social context of acupuncture in IVF patients, and examining the
reasons why the acupuncture may or may not have worked.
Methods: We will conduct a randomized controlled trial of acupuncture compared to placebo acupuncture.
Inclusion criteria include: women aged less than 43 years; undergoing a fresh IVF or ICSI cycle; and restricted to
women with the potential for a lower live birth rate defined as two or more previous unsuccessful ETs; and
unsuccessful clinical pregnancies of quality embryos deemed by the embryologist to have been suitable for
freezing by standard criteria. Women will be randomized to acupuncture or placebo acupuncture. Treatment is
administered on days 6 to 8 of the stimulated cycle and two treatments on the day of ET. A non-randomized
cohort of women not using acupuncture will be recruited to the study. The primary study outcome is the
proportion of women reporting a live birth. Secondary outcomes include the proportion of women reporting a
clinical pregnancy miscarriage prior to 12 weeks, quality of life, and self-efficacy. The sample size of the study is
1,168 women, with the aim of detecting a 7% difference in live births between groups (P= 0.05, 80% power).
Discussion: There remains a need for further research to add significant new knowledge to defining the exact role
of certain acupuncture protocols in the management of infertility requiring IVF from a clinical and cost-effectiveness
perspective.
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There are a greater number of women now attempting
pregnancy at an older age when they are less fertile; and
consequently a growing number of couples accessing
Assisted Reproductive Technologies (ART). In Australia
during 2008, there were 61,929 ART cycles, however
only 22.6% resulted in a clinical pregnancy and 17.2%
resulted in live deliveries [1]. In vitro fertilization (IVF)
is a resource-intensive and costly treatment option for
both women and their families, and for public healthcare
expenditure, and there is a significant personal cost to
couples undergoing repeated IVF cycles. Therefore new
therapies that improve reproductive and health out-
comes are highly desirable.
Complementary therapies and medicines are used by
individuals with infertility and eight surveys report
prevalence rates between 13% and 82% [2-9]. Acupunc-
ture has become an emerging therapy used as an adjunct
to IVF. A survey of UK acupuncturists indicates 15%
provide fertility support, and for some practitioners this
has become a large proportion of their caseload [10].
Eighty percent of acupuncturists reported most of this
work was related to assisted conception.
There is a growing body of research evaluating the
effect of acupuncture administered during IVF, and spe-
cifically on the day of embryo transfer (ET). The first
systematic review was published in 2008 and this review
found that acupuncture as an adjunct to ET was asso-
ciated with statistically and clinically significant increases
in the pregnancy, ongoing pregnancy, and live birth rates
[11]. Although these findings were encouraging they
were somewhat preliminary, and highlighted a need for
further placebo controlled trials, with improved repor-
ting of trials. Over the last 3 to 4 years several new trials
and systematic reviews have been published [12-15]. To
date many trials are heterogeneous and results inconsis-
tent. There are several possible explanations for the
heterogeneity of trials included in the systematic reviews.
Several reviews included a trial addressing a different
research question to other trials [16]. This trial also
reported a very high pregnancy rate in the control
group. The heterogeneity may also be attributed to the
combining of data from different control groups, for
example groups including IVF alone and no acupunc-
ture, the use of needles inserted into sham points, and
the use of non-invasive placebo needles. There was also
clinical heterogeneity in the treatment protocols used
between studies, with variation in the acupuncture
points used, timing of treatment, and frequency of acu-
puncture. There remains insufficient evidence to deter-
mine whether acupuncture can enhance live birth rates
when used as an adjunct to IVF treatment.
Our study aimed to reduce the methodological and
clinical heterogeneity observed in previous designs. WeArchived at Flinders Universidesigned a multicentered, randomized controlled trial
(RCT) that compares acupuncture with an acupuncture
control, and a non-randomized observational usual care
group. We undertook a Delphi study to achieve consen-
sus on the design of the optimal acupuncture treatment
protocol to be used in this research. The primary study
objective is to determine the clinical effectiveness of acu-
puncture with improving the proportion of women
undergoing IVF having live births, the key outcome in
trials of reproductive medicine. Secondary study objec-
tives include: methods to determine the cost-
effectiveness of IVF with acupuncture; and a qualitative
study to examine the personal and social context of acu-
puncture in IVF patients, examining the reasons why the
acupuncture may or may not have worked, and identify
other effects of acupuncture.
Methods/design
We will conduct a parallel randomized controlled trial
of acupuncture compared with a placebo control using a
non-invasive placebo needle. A non-randomized group
will receive standard care to allow comparisons with the
baseline pregnancy rate. The rationale for a non-
randomized arm includes the need to provide a baseline
pregnancy rate, and acknowledgement from our previ-
ous research experience that women would not accept
randomization to this group [17]. We acknowledge this
group of women may have different outcomes, and in-
corporating a usual care group to provide baseline preg-
nancy rate is problematic. The analysis of the usual care
only group will be treated as an observational study with
known confounding factors adjusted for in the analysis.
The study will recruit participants from IVF centers in
Australia (IVF Australia, Assisted Conception and Fertil-
ity South Australia, Flinders Reproductive) and one cen-
ter in New Zealand (Fertility Plus).
Eligibility criteria
We will recruit women aged <43 years, undergoing a
fresh IVF or intracytoplasmic sperm injection (ICSI)
cycle, and restricted to women with the potential for a
lower live birth rate defined as two or more previous un-
successful ETs (fresh or frozen), and unsuccessful clinical
pregnancies of quality embryos deemed by the embry-
ologist to have been suitable for freezing by standard cri-
teria. The rationale for our inclusion criteria is based on
a possibility that where the baseline pregnancy rates are
high for some IVF settings, the added value of acupunc-
ture maybe reduced. We have identified a group of
women were the pregnancy rates are lower, and for
whom adding acupuncture may improve their clinical
outcomes. The characteristics of age <43 years, under-
going a fresh IVF or intracytoplasmic sperm injection
(ICSI) cycle, reflect the characteristics of majority ofty: dspace.flinders.edu.au
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Zealand. IVF units outside of Australia and New Zealand
may have lower age restrictions.
Women will be excluded if they are undergoing a fro-
zen ET, have been previously randomized to the study,
planning pre-implantation genetic diagnosis, or receiving
donor eggs, or are currently having acupuncture.
Randomization and blinding
Women will be allocated to a study group by a research
nurse phoning the randomization service, prepared and
based at the National Health and Medical Research
Council Clinical Trials Centre, Sydney, Australia. The
randomization sequence is computer generated and con-
cealed via central allocation. There will be stratification
by the number of ET cycles (2 to 6 and 6+), woman’s age
(<38 years, and 38 to 42 years), and collaborating cen-
ter. Randomization will be into two study groups, acu-
puncture and a placebo control using the non-invasive
Park needle [18]. Study participants, care providers, the
outcome assessors, and the analyst will be blind to study
group allocation.
Interventions
Following randomization women in the intervention
groups will see the study acupuncturist based at the IVF
centers, or at close proximity to the IVF centers. The
acupuncturists are registered with national professional
associations, and with a minimum of 2 years clinical ex-
perience. Training will be provided to all study acupunc-
turists on the treatment protocol, practitioner intent or
treatment aspirations, recording of treatments adminis-
tered, the acupuncturists’ duty and an explanation of
proposed future monitoring. The treatment protocol was
based on two rounds of a Delphi process, with consen-
sus achieved on a treatment protocol for the study.
Nineteen acupuncturists participated in this process,
with practitioners from Australia (6), China (2), Den-
mark (1), Sweden (1), the United States (4), and the Uni-
ted Kingdom (1). All women will undergo a traditional
Chinese medicine (TCM) diagnosis. The initial diagnosis
and treatment will take 60 to 90 minutes undertaken on
days 6 to 8 of the stimulated IVF cycle. Two treatments
will be administered immediately before and after ET.
Group 1: Acupuncture treatment based on the trad-
itional Chinese medicine (TCM) style of acupuncture.
For women randomized to receive acupuncture the ini-
tial treatment includes core points Guilai ST-29, Gua-
nyuan Ren-4, Qihai Ren-6, Sanyinjiao SP-6, Xuehai SP-
10, plus up to five additional points based on a TCM
pattern differentiation. Two subsequent treatments will
be administered on the day of ET pre and post transfer.
Points administered on the day of ET include Diji SP-8,
Xuehai SP-10, Taichong LR-3, Guanyuan Ren-4, oneArchived at Flinders Universipoint from Shenmen HT-7, Neiguan PC-6, or YinTang,
Baihui DU-20, Taixi KD-3, Zusanli ST-36, Sanyinjiao SP-
6, and auricular points Shenmen and Zhigong. Manual
acupuncture will be performed with needles inserted
using the Park device [18], a supporting tube that facili-
tates maintenance of blinding for the participant. Nee-
dles will be inserted to a depth of not greater than 2 cm
and retained for 25 min. The insertion of the acupunc-
ture needle into an acupuncture point typically generates
a range of sensations called ‘de qi’, this sensation will be
maintained during the initial treatment on days 6 to 8,
and during the pre-embryo treatment only. Points will
be inserted bilaterally except for acupuncture points
located on the Ren and Du points and YinTang point.
Group 2: Placebo control. This group will receive
placement of non-invasive Park sham needles [18]. The
Park needle has been shown to be an effective device for
blinding in RCT [18]. These needles have a retractable
needle shaft, a blunt tip, and skin penetration does not
occur, and the needles have a supporting device. The
acupuncturist will hold the ‘needle’ in place with one
hand, while moving the handle of the needle with the
other hand, so the shaft disappears into the handle. The
needle is inserted through Park supporting device. The
location of sham non-acupuncture points are away from
real points and are described in relation to anatomical
landmarks and relationship to acupuncture channels.
Thirteen sham points are described: three on the abdo-
men, four on the arm, two on the leg, one on the back,
one on the forehead, one on the foot, and one on the
ear. The duration of needling and treatment session is
the same as for the acupuncture group.
Study group 3: Usual care only. For women who de-
cline to be randomized and were not planning to have
acupuncture, they will be invited to participate in a non-
randomized group receiving standard care only group,
and provide consent to participate in all data collection.
Outcome measures
Our primary study endpoint will be the proportion of
women reporting a live birth defined as the delivery of
one or more living infants, >20 weeks gestation or 400 g
or more birth weight. Our secondary endpoints will be
the proportion of women reporting a clinical pregnancy
defined as demonstration of fetal heart activity on ultra-
sound scan, measured at 7 to 8 weeks, miscarriage
defined as a non-viable pregnancy prior to 12 weeks,
quality of life using the MOS Short Form 36 (SF36) [19],
anxiety using the Stait Trait Anxiety Inventory [20] and
infertility self-efficacy measured by the Infertility Self-
Efficacy Scale [21] at trial entry, 2 and 14 weeks from
trial entry. We will also collect data on expectations, and
the therapeutic alliance. Clinical data will be collected
from the IVF center database. Other outcomes will bety: dspace.flinders.edu.au
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Figure 1 Study design.
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acupuncture and any adverse events will be collected
from practitioner treatment notes (Figure 1)Sample size
Our pilot data [17] were suggestive of a larger treatment
difference; however we have chosen a more conservative
7% estimate of the clinical effect from acupuncture com-
pared with the placebo control group. The proportion of
women with a live birth for women with multiple cycle
failures in the placebo control group in our previous
study was 12.1% [17]. To detect a 7% increase in the
proportion of women that report a live birth between
the treatment and placebo control, with 80% power at
the 5% significance level will require 449 women perArchived at Flinders Universigroup. We have allowed for a loss of 30% due to can-
celled cycles, or no ET. A total sample size of 1,168
women is required.
We expect a larger treatment effect (10%) when com-
paring acupuncture and standard care. To detect a 10%
increase in the proportion of women that report a live
birth between the treatment and standard care, with
80% power at the 5% significance level will require 193
women in the non-randomized group. Allowing for a
30% loss, due to cancelled cycles, or no ET, 251 women
in the non-randomized group are required.Data analysis
Data will be analyzed by a statistician based at UWS
blind to study group. Analyses of the endpoints willty: dspace.flinders.edu.au
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differences in the primary and secondary endpoints be-
tween groups. The primary analysis will compare the
proportions of patients with live births. Logistic regres-
sion will be used to identify baseline variables which are
associated with outcomes. Linear models will be used to
test for between group differences in the continuous
outcome measures (for example, health status).
Subgroup analyses will be stated a priori, for example
influence of stimulation doses, long- or short-acting
stimulation cycle. Levels of significance will be reported
at P< 0.05.
Qualitative study
A qualitative study using in-depth interviews is nested
within the RCT. The purpose of the interviews is: to in-
vestigate how women perceive the study intervention
and how they think about their use and experience of it,
and its effects; and to provide evidence of the process by
which the outcomes of the RCT may have been
achieved. A sample of 50 women will be recruited
through theoretical and purposive sampling to ensure
equal numbers of participants from both the interven-
tion and placebo control groups, and a socially diverse
sample of women across demographic background,
treatment outcome and coping outcomes (as determined
by the self-efficacy scores). It is anticipated that 50 inter-
views will lead to data saturation. The interview will
cover topics such as the women’s experience of IVF
treatment and its impact on personal wellbeing and so-
cial and family relationships, and women’s perception of
the impact of acupuncture. Interviews will examine their
experience during the period following ET and the preg-
nancy test. Their beliefs about the impact of acupunc-
ture on their bodies and health, and its potential impact
on the reproductive outcome of their treatment will be
explored in conversation. Analysis of qualitative inter-
view data will be iterative and the interview schedule will
be modified to include emerging themes.
Economic analysis
An economic analysis will be conducted alongside the
RCT. The primary measure of outcome for the economic
analysis will be the cost per live birth. Resource use col-
lected within the study will include costs associated with
the provision of the proposed acupuncture intervention
plus the direct costs of IVF based on expected average
clinic fees, the frequency and duration of GP visits, the fre-
quency and duration of antenatal visits and inpatient
admissions, for example miscarriage loss or antenatal com-
plications. Mean costs and effectiveness between the inter-
vention and control groups will be compared and
incremental cost-effectiveness ratios (ICERs) presented in
terms of the cost per unit improvement in clinical outcomeArchived at Flinders Universias measured by the live birth rate. An assessment of the
sensitivity of the results obtained to variation in measured
resource use, effectiveness and/or unit costs will be under-
taken using appropriate one-way and multi-way sensitivity
analysis [22]. Data will be collected from Medicare, a na-
tional database of health utilization, activity and resource
use, and completion of data forms by women reporting
health utilization not captured by Medicare.
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Discussion
IVF is a costly treatment option for women, their part-
ners and the public, and there is a significant personal
cost to couples undergoing repeated IVF cycles. There-
fore new therapies that improve reproductive and health
outcomes are highly desirable. Acupuncture is an emer-
ging therapy used as an adjunct to IVF, and it is import-
ant to healthcare consumers and healthcare providers
that the evidence base for this modality be established.
This research will add significant new knowledge to
defining the role of certain acupuncture protocols ap-
plied on the day of ET and one other day of the IVF
from a clinical and cost-effectiveness perspective. The
study design utilizing mixed methods will also generate
a different form of new knowledge that will allow the so-
cial and personal experience of acupuncture to be
explained and their relationship to acupuncture deter-
mined. The research will add significantly to the clinical
evidence base to allow conclusions to be made on the
role of acupuncture to improve reproductive outcomes.
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This trial is currently recruiting participants.
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